Pharmaceutical Form: Powder and solvent for solution for injection/infusion

2 trials

Sponsors

Bayer AG

Conditions

Hemophilia A MedDRA version: 20.0 Level: LLT Classification code 10053753 Term: Hemophilia A without inhibitors System Organ Class: 100000004850

Phase 2

A prospective, lead-in study to collect bleeding episodes, Factor VIII (FVIII) infusions, and patient-reported outcomes in patients with hemophilia A

Not yet recruitingEUCTR2019-004480-48-ES

Bayer AGHemophilia A MedDRA version: 20.0 Level: LLT Classification code 10053753 Term: Hemophilia A without inhibitors System Organ Class: 100000004850

Start: 2021-12-14Target: 140Updated: 2021-12-21

A study to learn more about bleeding episodes, the use of treatments containing a protein called clotting factor 8 (FVIII), and how the patients felt about their symptoms and pain, in people with hemophilia A

Not yet recruitingEUCTR2019-004480-48-NL

Bayer AGHemophilia A MedDRA version: 20.0 Level: LLT Classification code 10053753 Term: Hemophilia A without inhibitors System Organ Class: 100000004850

Start: 2021-11-05Target: 140Updated: 2021-11-15